BACK TO TEAM

Ed Wu, PhD

Head of Medicinal Chemistry

  • Leads medicinal chemistry efforts for all of Myrobalan’s portfolio
  • Experienced medicinal chemist with 20 years of industry experience and a successful track record of success
  • Expertise from hit identification to lead optimization, resulting in delivery of multiple pre-clinical and clinical candidates.
  • Led the development of multiple small molecule programs at Alantos (acquired by Amgen), Hydra Biosciences, Mitobridge (acquired by Astellas), and Tango Therapeutics
  • Ph.D. in Organic Chemistry and Post doctorate research at SUNY Stony Brook, B.S., Chemistry Peking University
Ed Wu, PhD